Pages that link to "Q98148377"

The following pages link to Radka Platte (Q98148377):

Displaying 38 items.

• DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers (Q21144874) (← links)
• CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen (Q21195205) (← links)
• Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers (Q24655824) (← links)
• Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk (Q27008356) (← links)
• No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (Q30374367) (← links)
• Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. (Q31043651) (← links)
• Common genetic variants and modification of penetrance of BRCA2-associated breast cancer (Q33742096) (← links)
• Exploring the link between MORF4L1 and risk of breast cancer (Q33863235) (← links)
• Fine scale mapping of the breast cancer 16q12 locus (Q33878276) (← links)
• Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls (Q34123806) (← links)
• CYP2D6 gene variants and their association with breast cancer susceptibility (Q34180983) (← links)
• Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study (Q34240634) (← links)
• Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction (Q34394665) (← links)
• Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status (Q34700093) (← links)
• Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers (Q34963894) (← links)
• Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (Q35155449) (← links)
• Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers (Q35382206) (← links)
• Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (Q35523236) (← links)
• Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium (Q35532898) (← links)
• Identification of six new susceptibility loci for invasive epithelial ovarian cancer (Q35541663) (← links)
• An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (Q35618307) (← links)
• Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers (Q35870067) (← links)
• Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer (Q35957703) (← links)
• A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers (Q36152991) (← links)
• Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers (Q36280191) (← links)
• Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers (Q36393232) (← links)
• Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk (Q36720814) (← links)
• Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers (Q36839777) (← links)
• Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (Q36897003) (← links)
• Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. (Q37300024) (← links)
• No evidence that GATA3 rs570613 SNP modifies breast cancer risk (Q37308596) (← links)
• Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. (Q37356243) (← links)
• Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers (Q37434133) (← links)
• A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity (Q39200585) (← links)
• Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. (Q44946113) (← links)
• Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer. (Q45793899) (← links)
• Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (Q57266620) (← links)
• High-throughput genotyping of high-homology mutant mouse strains by next-generation sequencing (Q100954813) (← links)